The new material is capable of absorbing pharmaceutical drugs and allows the formation of blood vessels within the material’s pores, which increases the chances for a successful integration of the implant.
The experimental model created by IK4-CIDETEC is at the preclinical trial stage of testing.
More Articles on Ophthalmology:
Dr. David Ewing-Chow to Open Solo Practice
California Laws Prohibiting ‘One-Stop’ Optician Stores Remain Intact
American Academy of Ophthalmology Joins Choosing Wisely Campaign
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
